Invention Grant
- Patent Title: Teverelix-TFA composition
-
Application No.: US17740743Application Date: 2022-05-10
-
Publication No.: US12070484B2Publication Date: 2024-08-27
- Inventor: Guy Poland , Francois Boutignon
- Applicant: Antev Limited
- Applicant Address: GB London
- Assignee: Antev Limited
- Current Assignee: Antev Limited
- Current Assignee Address: GB London
- Agency: Fox Rothschild LLP
- Priority: EP 181945 2018.07.05
- Main IPC: A61K38/09
- IPC: A61K38/09 ; A61K9/08 ; A61K47/12 ; A61P5/00 ; A61P13/00 ; A61P35/00
Abstract:
Provided is a teverelix-TFA composition having a molar ratio of teverelix to trifluoroacetate composition of at least 1:2.2. Such a molar ratio will prevent undesirable gel-formation and provide a homogenous suspension, whereby a unique bioavailablity of teverelix is obtained.
Public/Granted literature
- US20220273758A1 TEVERELIX-TFA COMPOSITION Public/Granted day:2022-09-01
Information query
IPC分类:
